Team Bio

Dr. Jitakshi is a graduate of Duke University School of Medicine, and received her Baccalaureate of Science in Biology summa cum laude from UNC – Chapel Hill. As a Howard Hughes Medical Institute Medical Student Fellowship Recipient at NIEHS (Research Triangle Park, NC), she discovered an unusual CCCH type of Zn++ finger transcription factor with a role in early development of Xenopus. Upon completion of her residency in anatomic and clinical pathology at the University of Texas Houston Health Science Center, she pursued her fellowship in hematopathology at the University of Michigan Hospital. Dr. De is a physician scientist with licensure in California, Michigan, Texas and New York and a diplomate of the American Board of Pathology. She is a Fellow of the College of American Pathologists (CAP) since 2008 and of the American Society for Clinical Pathology (ASCP) since 2009. She has authored/co-authored 14 peer-reviewed publications and numerous abstract presentations in diverse areas including chronic lymphocytic leukemia prognostic factors, signal transduction pathways in classical Hodgkin lymphoma, acute myeloid leukemia-associated genetic point mutations and chromosomal translocations, genotypic-phenotypic correlations, multi-parametric flow cytometry-based diagnostics for hematologic neoplasms, mass spectrometry, rare stem/progenitor cell detection and characterization, and target-specific lead discovery. She was a recipient of the CAP Fellowship in Hematopathology (’06) and has received a stem cell research award from BD Biosciences (’13). Besides being an entrepreneur, she is deeply interested in deciphering cell-cell signaling interactions in oncogenic states.

Jita De

Dr. Jitakshi is a graduate of Duke University School of Medicine, and received her Baccalaureate of Science in Biology summa cum laude from UNC – Chapel Hill. As a Howard Hughes Medical Institute Medical Student Fellowship Recipient at NIEHS (Research Triangle Park, NC), she discovered an unusual CCCH type of Zn++ finger transcription factor with a role in early development of Xenopus. Upon completion of her residency in anatomic and clinical pathology at the University of Texas Houston Health Science Center, she pursued her fellowship in hematopathology at the University of Michigan Hospital. Dr. De is a physician scientist with licensure in California, Michigan, Texas and New York and a diplomate of the American Board of Pathology. She is a Fellow of the College of American Pathologists (CAP) since 2008 and of the American Society for Clinical Pathology (ASCP) since 2009. She has authored/co-authored 14 peer-reviewed publications and numerous abstract presentations in diverse areas including chronic lymphocytic leukemia prognostic factors, signal transduction pathways in classical Hodgkin lymphoma, acute myeloid leukemia-associated genetic point mutations and chromosomal translocations, genotypic-phenotypic correlations, multi-parametric flow cytometry-based diagnostics for hematologic neoplasms, mass spectrometry, rare stem/progenitor cell detection and characterization, and target-specific lead discovery. She was a recipient of the CAP Fellowship in Hematopathology (’06) and has received a stem cell research award from BD Biosciences (’13). Besides being an entrepreneur, she is deeply interested in deciphering cell-cell signaling interactions in oncogenic states.